BRIEF published on 11/26/2024 at 00:25, 9 days 11 hours ago NexgenRx Reports Q3 Growth and Announces Dividend Financial Results Revenue Increase Dividend Declaration SaaS Solutions EBITDA Growth
BRIEF published on 11/26/2024 at 00:25, 9 days 11 hours ago NexgenRx annonce une croissance au troisième trimestre et un dividende Résultats Financiers Solutions SaaS Augmentation Des Revenus Croissance De L'EBITDA Déclaration De Dividendes
PRESS RELEASE published on 11/26/2024 at 00:20, 9 days 11 hours ago NexgenRx Announces Third Quarter Results and Declaration of Divdend NexgenRx announces Q3 2024 financial results, with quarterly revenue up to $4,158,667 and increased positive EBITDA of $446,448. A dividend of $0.005 per share declared for shareholders Financial Results Revenue Dividend Q3 2024 NexgenRx
BRIEF published on 10/07/2024 at 23:35, 1 month 28 days ago NexgenRx Re-Appoints Charles Burns to Board of Directors Technology Solutions Board Appointment Canada NexgenRx Charles Burns
BRIEF published on 10/07/2024 at 23:35, 1 month 28 days ago NexgenRx reconduit Charles Burns au sein de son conseil d'administration Canada Nomination Au Conseil D'administration Solutions Technologiques NexgenRx Charles Burns
PRESS RELEASE published on 10/07/2024 at 23:30, 1 month 28 days ago NexgenRx Announces Director Re-Appointment NexgenRx Inc. announces re-appointment of Charles Burns to its Board of Directors. Company provides full-service Third-Party Administrator & Technology Solutions in Canada Board Of Directors Technology Solutions Third-party Administrator NexgenRx Inc. Charles Burns
BRIEF published on 10/01/2024 at 14:05, 2 months 3 days ago NexgenRx Appoints Linda Brennan to Board of Directors Board Of Directors Corporate Governance Appointment NexgenRx Linda Brennan
BRIEF published on 10/01/2024 at 14:05, 2 months 3 days ago NexgenRx nomme Linda Brennan au conseil d'administration Conseil D'administration Gouvernance D'Entreprise Rendez-vous NexgenRx Linda Brennan
PRESS RELEASE published on 10/01/2024 at 14:00, 2 months 3 days ago NexgenRx Announces New Director NexgenRx announces the appointment of Linda Brennan as a new member to its Board of Directors. Linda brings expertise in finance and corporate governance to the company Board Of Directors Appointment Finance NexgenRx Linda Brennan
BRIEF published on 07/18/2024 at 20:05, 4 months 17 days ago NexgenRx Announces Share Issuances Under Consulting Agreement Consulting Agreement Share Issuance NexgenRx PBM Management Services SaaS Model
Published on 12/05/2024 at 11:00, 38 minutes ago Kingfisher Signs Definitive Agreement to Acquire the Ball Creek West (BAM) Project
Published on 12/05/2024 at 00:00, 11 hours 38 minutes ago Electric Royalties Closes Acquisition of 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 12/04/2024 at 23:25, 12 hours 13 minutes ago Supreme Critical Metals Inc. Update on Project, Debt Settlements and Cancellations of Incentive Stock Options
Published on 12/04/2024 at 23:00, 12 hours 38 minutes ago Gold Terra Announces Closing of Non-Flow-Through Portion of the Non-Brokered Private Placement
Published on 12/04/2024 at 22:55, 12 hours 43 minutes ago TACACS.net: Strengthening Network Security with Native Active Directory Integration
Published on 12/05/2024 at 11:20, 17 minutes ago Aareal Bank provides €214 million refinancing for the largest outlet centre in northern Germany
Published on 12/05/2024 at 11:15, 23 minutes ago Africa Finance Corporation (AFC)-led Zambia Lobito Rail Project receives boost from Biden visit to Angola
Published on 12/05/2024 at 11:09, 28 minutes ago thyssenkrupp nucera Strengthens Cyber Security With ISO 27001 Certificate
Published on 12/05/2024 at 11:01, 36 minutes ago naoo AG Completes Successful Stock Market Listing in Germany
Published on 12/05/2024 at 10:58, 40 minutes ago Strategic Realignment: USU Accelerates Innovation and Brand Expansion
Published on 12/05/2024 at 08:30, 3 hours 8 minutes ago Capital Market Day: Updating Mersen’s roadmap
Published on 12/05/2024 at 08:30, 3 hours 8 minutes ago Capital Market Day : Actualisation de la feuille de route de Mersen
Published on 12/05/2024 at 08:02, 3 hours 36 minutes ago NFL BIOSCIENCES VALIDE L’INDUSTRIALISATION DE NFL-101 POUR LE SEVRAGE TABAGIQUE
Published on 12/05/2024 at 08:02, 3 hours 36 minutes ago NFL BIOSCIENCES VALIDATES THE INDUSTRIALIZATION OF NFL-101 FOR SMOKING CESSATION
Published on 12/05/2024 at 07:55, 3 hours 43 minutes ago Safran 2024 Capital Markets Day (CMD’24): Safran is poised to deliver a further period of profitable growth
